Additionally, Lee et al. (2019) [111] demonstrated that sEH deletion in an AD mice model (APP/PS1) reduced and delayed the development of cognitive impairment and specific markers of the disease such as β-amyloid deposition and apoE expression. Here, EPHX2 is linked to Alzheimer disease.